止血剤の米国市場

【英語タイトル】UNITED STATES HEMOSTATIC AGENTS MARKET INSIGHTS, FORECAST TO 2027

QYResearchが出版した調査資料(HNI409SP2099)・商品コード:HNI409SP2099
・発行会社(調査会社):QYResearch
・発行日:2021年2月
・ページ数:約110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:米国
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,200 ⇒換算¥352,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,800 ⇒換算¥528,000見積依頼/購入/質問フォーム
Enterprise License(法人閲覧用)USD6,400 ⇒換算¥704,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

The United States Hemostatic Agents market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX during 2021-2027.
Hemostatic Agents market is segmented by type, and by application. Players, stakeholders, and other participants in the United States Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by type, and by application for the period 2016-2027.

Segment by Type
 Factor Concentrators
 Mucoadhesive Agents
 Procoagulant Supplementors

Segment by Application
 Hospitals
 Surgical Centers
 Nursing Homes

By Company
 Johnson & Johnson
 GELITA MEDICAL GmbH
 Pfizer
 Baxter
 B Braun

【レポートの目次】

1 STUDY COVERAGE
1.1 Hemostatic Agents Product Introduction
1.2 Market by Type
1.2.1 United States Hemostatic Agents Market Size Growth Rate by Type
1.2.2 Factor Concentrators
1.2.3 Mucoadhesive Agents
1.2.4 Procoagulant Supplementors
1.3 Market by Application
1.3.1 United States Hemostatic Agents Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 United States Hemostatic Agents Market Size Estimates and Forecasts
1.4.1 United States Hemostatic Agents Sales Estimates and Forecasts 2016-2027
1.4.2 United States Hemostatic Agents Revenue Estimates and Forecasts 2016-2027
1.5 Study Objectives
1.6 Years Considered
2 COMPETITION BY MANUFACTURER
2.1 United States Hemostatic Agents Sales by Manufacturer
2.1.1 United States Hemostatic Agents Sales by Manufacturer (2016-2021)
2.1.2 United States Hemostatic Agents Manufacturers Market Share by Sales (2016-2021)
2.1.3 United States 3 and Top 5 Companies by Hemostatic Agents Sales in 2020
2.2 United States Hemostatic Agents Revenue by Manufacturer
2.2.1 United States Hemostatic Agents Manufacturers by Revenue (2016-2021)
2.2.2 United States Hemostatic Agents Manufacturers Market Share by Revenue (2016-2021)
2.2.3 United States 3 and Top 5 Companies by Hemostatic Agents Revenue in 2020
2.3 United States Hemostatic Agents Sales Price by Manufacturer
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.4.2 United States Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Hemostatic Agents Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3 MARKET SIZE BY TYPE
3.1 United States Hemostatic Agents Sales by Type
3.1.1 United States Hemostatic Agents Historical Sales by Type (2016-2021)
3.1.2 United States Hemostatic Agents Forecasted Sales by Type (2022-2027)
3.1.3 United States Hemostatic Agents Sales Market Share by Type (2016-2027)
3.2 United States Hemostatic Agents Revenue by Type
3.2.1 United States Hemostatic Agents Historical Revenue by Type (2016-2021)
3.2.2 United States Hemostatic Agents Forecasted Revenue by Type (2022-2027)
3.2.3 United States Hemostatic Agents Revenue Market Share by Type (2016-2027)
3.3 United States Hemostatic Agents Price by Type
3.3.1 United States Hemostatic Agents Price by Type (2016-2021)
3.3.2 United States Hemostatic Agents Price Forecast by Type (2022-2027)
4 MARKET SIZE BY APPLICATION
4.1 United States Hemostatic Agents Sales by Application
4.1.1 United States Hemostatic Agents Historical Sales by Application (2016-2021)
4.1.2 United States Hemostatic Agents Forecasted Sales by Application (2022-2027)
4.1.3 United States Hemostatic Agents Sales Market Share by Application (2016-2027)
4.2 United States Hemostatic Agents Revenue by Application
4.2.1 United States Hemostatic Agents Historical Revenue by Application (2016-2021)
4.2.2 United States Hemostatic Agents Forecasted Revenue by Application (2022-2027)
4.2.3 United States Hemostatic Agents Revenue Market Share by Application (2016-2027)
4.3 United States Hemostatic Agents Price by Application
4.3.1 United States Hemostatic Agents Price by Application (2016-2021)
4.3.2 United States Hemostatic Agents Price Forecast by Application (2022-2027)
5 CORPORATE PROFILE
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Corporation Information
5.1.2 Johnson & Johnson Overview
5.1.3 Johnson & Johnson in United States: Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
5.1.4 Johnson & Johnson Hemostatic Agents Product Description
5.1.5 Johnson & Johnson Recent Developments
5.2 GELITA MEDICAL GmbH
5.2.1 GELITA MEDICAL GmbH Corporation Information
5.2.2 GELITA MEDICAL GmbH Overview
5.2.3 GELITA MEDICAL GmbH in United States: Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
5.2.4 GELITA MEDICAL GmbH Hemostatic Agents Product Description
5.2.5 GELITA MEDICAL GmbH Recent Developments
5.3 Pfizer
5.3.1 Pfizer Corporation Information
5.3.2 Pfizer Overview
5.3.3 Pfizer in United States: Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
5.3.4 Pfizer Hemostatic Agents Product Description
5.3.5 Pfizer Recent Developments
5.4 Baxter
5.4.1 Baxter Corporation Information
5.4.2 Baxter Overview
5.4.3 Baxter in United States: Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
5.4.4 Baxter Hemostatic Agents Product Description
5.4.5 Baxter Recent Developments
5.5 B Braun
5.5.1 B Braun Corporation Information
5.5.2 B Braun Overview
5.5.3 B Braun in United States: Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
5.5.4 B Braun Hemostatic Agents Product Description
5.5.5 B Braun Recent Developments
6 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
6.1 Hemostatic Agents Industry Chain Analysis
6.2 Hemostatic Agents Key Raw Materials
6.2.1 Key Raw Materials
6.2.2 Raw Materials Key Suppliers
6.3 Hemostatic Agents Production Mode & Process
6.4 Hemostatic Agents Sales and Marketing
6.4.1 Hemostatic Agents Sales Channels
6.4.2 Hemostatic Agents Distributors
6.5 Hemostatic Agents Customers
7 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS
7.1 Hemostatic Agents Industry Trends
7.2 Hemostatic Agents Market Drivers
7.3 Hemostatic Agents Market Challenges
7.4 Hemostatic Agents Market Restraints
8 KEY FINDINGS IN THE UNITED STATES HEMOSTATIC AGENTS STUDY
9 APPENDIX
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer



★調査レポート[止血剤の米国市場] (コード:HNI409SP2099)販売に関する免責事項を必ずご確認ください。
★調査レポート[止血剤の米国市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆